Splenectomy in Patients With Myeloproliferative Neoplasms: Efficacy, Complications and Impact on Survival and Transformation

Leukemia and Lymphoma - United Kingdom
doi 10.3109/10428194.2013.794269
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Circulating Endothelial Cells in Patients With Venous Thromboembolism and Myeloproliferative Neoplasms

PLoS ONE
Multidisciplinary
2013English

Survival of Patients With Chronic Myeloproliferative Neoplasms and New Primary Cancers: A Population-Based Cohort Study

The Lancet Haematology
Hematology
2015English

JAK2, CALR, and MPL Mutation Spectrum in Japanese Patients With Myeloproliferative Neoplasms

Haematologica
Hematology
2014English

JAK2 Exon 14 Deletion in Patients With Chronic Myeloproliferative Neoplasms

PLoS ONE
Multidisciplinary
2010English

A Spotlight on the Management of Complications Associated With Myeloproliferative Neoplasms: A Clinician’s Perspective

Expert Review of Hematology
Hematology
2017English

High Concordance in Grading Reticulin Fibrosis and Cellularity in Patients With Myeloproliferative Neoplasms

Modern Pathology
Forensic MedicinePathology
2014English

Italian Survey on Clinical Practice in Myeloproliferative Neoplasms. A GIMEMA Myeloproliferative Neoplasms Working Party Initiative

American Journal of Hematology
Hematology
2019English

AML1/RUNX1 Point Mutation Possibly Promotes Leukemic Transformation in Myeloproliferative Neoplasms

Blood
BiochemistryImmunologyCell BiologyHematology
2009English

Lymphoproliferative Disorders in Patients With Chronic Myeloproliferative Neoplasms: A Systematic Review

American Journal of Hematology
Hematology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy